quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:21·1320d
SECFiling
Brickell Biotech Inc. logo

SEC Form EFFECT filed by Brickell Biotech Inc.

BBI· Brickell Biotech Inc.
Health Care
Original source

Companies

  • BBI
    Brickell Biotech Inc.
    Health Care

Recent analyst ratings

  • Mar 8UpdateWilliam Blair-
  • Jan 18UpdateHC Wainwright & Co.$2.00

Related

  • PR661d
    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Floor & Decor Holdings, Inc. (NYSE: FND)
  • SEC1260d
    SEC Form 10-Q filed by Brickell Biotech Inc.
  • SEC1260d
    Brickell Biotech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC1311d
    Brickell Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR1318d
    Fresh Tracks Therapeutics Initiates Multiple Ascending Dose Portion of Phase 1 Study of DYRK1A Inhibitor FRTX-02
  • SEC1323d
    Brickell Biotech Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • NEWS1324d
    Brickell Biotech's Return On Capital Employed Insights
  • PR1324d
    Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022